VYNE Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Latest Ratings for VYNE

Date Firm Action From To
Dec 2021 HC Wainwright & Co. Assumes Buy
May 2021 HC Wainwright & Co. Maintains Buy
Oct 2020 HC Wainwright & Co. Maintains Buy

View More Analyst Ratings for VYNE

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *